Back to Search Start Over

Discovery and development of potent and selective inhibitors of histone methyltransferase g9a.

Authors :
Sweis RF
Pliushchev M
Brown PJ
Guo J
Li F
Maag D
Petros AM
Soni NB
Tse C
Vedadi M
Michaelides MR
Chiang GG
Pappano WN
Source :
ACS medicinal chemistry letters [ACS Med Chem Lett] 2014 Jan 02; Vol. 5 (2), pp. 205-9. Date of Electronic Publication: 2014 Jan 02 (Print Publication: 2014).
Publication Year :
2014

Abstract

G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.

Details

Language :
English
ISSN :
1948-5875
Volume :
5
Issue :
2
Database :
MEDLINE
Journal :
ACS medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
24900801
Full Text :
https://doi.org/10.1021/ml400496h